Is a complete RMTI research report available?

No complete published report is available for Rockwell Medical, Inc. (RMTI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Rockwell Medical, Inc. (RMTI)

NASDAQ: RMTI · USD

$7.10

+0.22 (+3.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first RMTI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	28M
Revenue (ttm)	67.7M
Net income (ttm)	-5.6M
EPS (ttm)	-$1.49
Shares out	3.9M
Volume	11,522
Beta	1.61
Price target	$30.0	+322.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 67.7M
Net income (ttm): -5.6M
EPS (ttm): -$1.49
Market cap: 28M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RMTI indicators

Market & fundamental data

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001041024
Company name	Rockwell Medical, Inc.
Country	United States
Country code	US
Cusip	774374409
Employees	157
Employees Change	-87%
Employees Change Percent	-35.66
Enterprise value	$18.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	117.5
Industry PE Fwd	14.07
IPO Date	1998-01-27
Isin	US7743744093
Last refreshed	2026-07-31
Market cap	$28M
Market cap category	Nano-Cap
Price	$7.1
Price currency	USD
Rev Per Employee	431,082.8x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	RMTI
Website	https://www.rockwellmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.83%
EV Sales Forward	0.25x
EV/FCF	10.54x
EV/Sales	0.27x
FCF yield	6.27%
P/B ratio	0.78x
P/S ratio	0.41x
PS Forward	0.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.11%
EBITDA Margin	-0.76%
FCF margin	2.6%
Gross margin	17.07%
Gross Profit	$11.6M
Gross Profit Growth	-33.86%
Gross Profit Growth Q	-4.77%
Gross Profit Growth3 Y	15.68%
Gross Profit Growth5 Y	41.82%
Net Income	$-5.6M
Net Income Growth Years	0%
Pretax Margin	-7.98%
Profit Margin	-7.98%
Profit Per Employee	$-35,395
ROA	-5.4
Roa5y	-12.97
ROCE	-10.12
ROE	-16.04
Roe5y	-93.45
ROIC	-6.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-38.29%
Cagr15y	-28.88%
Cagr1y	-30.41%
Cagr20y	-20.59%
Cagr3y	-41.68%
Cagr5y	-38.65%
EPS Growth Years	0
FCF Growth	-18.66%
OCF Growth	-14.02%
Revenue Growth	-30.75x
Revenue Growth Q	-8.34x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.94x
Revenue Growth5 Y	1.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.22
Assets	$57.4M
Cash	$23.9M
Current Assets	$36.9M
Current Liabilities	$9.9M
Debt	$14.4M
Debt Equity	$0.4
Debt FCF	$8.19
Equity	$35.9M
Interest Coverage	-4.26
Liabilities	$21.6M
Long Term Assets	$20.5M
Long Term Liabilities	$11.7M
Net Cash	$9.5M
Net Cash By Market Cap	$33.9
Net Cash Growth	112.86%
Net Debt Equity	$-0.26
Net Debt FCF	$-5.41
Tangible Book Value	$25.4M
Tangible Book Value Per Share	$6.44
WACC	10.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.74
Inventory Turnover	13.86
Net Working Capital	$5.9M
Quick ratio	3.32
Working Capital	$27.1M
Working Capital Turnover	$2.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.65%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.2%
1Y total return	-30.39%
200-day SMA	8.88
3Y total return	-80.17%
50-day SMA	6.57
50-day SMA vs 200-day SMA	50under200
5Y total return	-91.31%
All Time High	2,079
All Time High Change	-99.66%
All Time High Date	2015-07-17
All Time Low	4.89
All Time Low Change	45.34%
All Time Low Date	2026-07-02
ATR	0.45
Beta	1.61
Beta1y	0.68
Beta2y	1.41
Ch YTD	-14.82
High	7.34
High52	21
High52 Date	2025-08-29
High52ch	-66.19%
Low	6.63
Low52	4.89
Low52 Date	2026-07-02
Low52ch	45.34%
Ma50ch	8%
Price vs 200-day SMA	-20.08%
RSI	64.18
RSI Monthly	39.57
RSI Weekly	42.67
Sharpe ratio	-0.13x
Sortino ratio	-0.13
Total Return	-15.65%
Tr YTD	-14.82
Tr15y	-99.4%
Tr1m	20.87%
Tr1w	8.81%
Tr3m	-21.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$20
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.24
Earnings Revenue Estimate	17,837,600x
Earnings Revenue Estimate Growth	10.99x
Operating Income	$-4.8M
Operating margin	-7.11
Price target	$30
Price Target Change	$323
Price Target Change Top	$182

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,505,100%
Float Percent	88.8%
Net Borrowing	-1,159,000
Shares Insiders	2.11%
Shares Institutions	14.49%
Shares Out	3,947,029
Shares Qo Q	0.03%
Shares Yo Y	15.65%
Short Float	2.44%
Short Ratio	2.05
Short Shares	2.17

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-93,000
Adjusted OCF	811,000
Average Volume	37,501.45x
Bv Per Share	9.08
CAPEX	$-904,000
Ch10y	-99.2
Ch15y	-99.4
Ch1m	20.87
Ch1w	8.81
Ch1y	-30.39
Ch20y	-99.01
Ch3m	-21.1
Ch3y	-80.17
Ch5y	-91.31
Ch6m	-34.86
Change	3.2%
Change From Open	1.28
Close	6.88
Days Gap	1.89
Depreciation Amortization	2,164,000
Dollar Volume	81,806.2
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-4.8M
EBITDA	$-512,000
EPS	$-1.49
F Score	4
FCF	$1.8M
FCF EV Yield	9.49x
FCF Per Share	$0.45
Financing CF	4,222,000
Fiscal Year End	December
Founded	1,994
Goodwill	921,000
Investing CF	-8,665,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2026-07-01
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	8.51
Ma150ch	-16.53%
Ma20	6.16
Ma20ch	15.28%
Net CF	-1,782,000
Next Earnings Date	2026-08-13
Open	7.01
Optionable	Yes
P FCF Ratio	15.95
P OCF Ratio	10.53
P OCF Ratio SBC	34.55
Position In Range	66.2
Post Close	7.1
Postmarket Change Percent	0
Postmarket Price	$7.1
Ppne	9,485,000
Price Date	2026-07-30
Ptbv Ratio	1.1
Relative Volume	0.31x
Revenue	67,680,000x
SBC By Revenue	2.73x
Share Based Comp	1,850,000
Tr20y	-99.01%
Tr6m	-34.86%
Us State	Michigan
Volume	11,522
Z Score	-7.33

Rockwell Medical, Inc. (RMTI)

Coverage state: Market snapshot only — no published research

Generate the first RMTI analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · RMTI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RMTI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RMTI

Frequently asked questions